Full Year 2024 Results Key Financial Results Revenue: US$610.8m (down 1.3% from FY ...

Analyst Mike Parkin: “Kinross maintains significant opportunities for growth within its North American portfolio, which should help to further improve its geopolitical risk profile. This includes the ...

CEO Serge Saxonov highlighted strong growth across platforms, with total revenue for Q4 2023 reaching $184 million, an 18% increase year-over-year. Spatial products contributed significantly, with ...

Wall Street analysts expect 10x Genomics (TXG) to post quarterly loss of $0.32 per share in its upcoming report, which indicates a year-over-year increase of 22%. Revenues are expected to be $158. ...

In trading on Monday, shares of 10x Genomics Inc (Symbol: TXG) entered into oversold territory, hitting an RSI reading of 27.9, after changing hands as low as $11.8955 per share. By comparison ...

Thank you for standing by. My name is [Prilla] and I will be your conference operator today. At this time, I would like to welcome everyone to the 10x Genomics Fourth Quarter and Full Year 2024 ...

10x Genomics (TXG) came out with a quarterly loss of $0.40 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.41 per share a year ago. These figures are ...

10x Genomics (NASDAQ:TXG – Get Free Report) had its price target lowered by analysts at Barclays from $19.00 to $18.00 in a research note issued to investors on Monday,Benzinga reports.

10x Genomics Price Performance NASDAQ:TXG opened at $12.06 on Tuesday. The company’s 50-day moving average is $14.98 and its two-hundred day moving average is $17.56. 10x Genomics, Inc. has a 1 ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2024 results beating Wall Street’s revenue expectations , but sales fell by 10.3% year on year to $165 million. On the other hand, the company’s ...

The news likely elevates concern on names like Bruker (BRKR), genomics Illumina (ILMN), 10x Genomics (TXG), and PacBio (PACB) and Thermo Fisher (TMO), Avantor (AVTR), Agilent (A), and Waters (WAT ...